• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Donate Now
  • Sign Up

Center for Medicare Advocacy

Advancing Access to Medicare and Healthcare

  • Eligibility/Enrollment
  • Coverage/Appeals
    • Medicare Costs (2020 & 2021)
    • Self Help Materials – Toolkits & More
  • Topics
    • Basic Introduction to Medicare
    • COVID-19 and Medicare
    • Medicare Costs (2020 & 2021)
    • Home Health Care
    • Improvement Standard and Jimmo News
    • Nursing Home / Skilled Nursing Facility Care
    • Outpatient Observation Status
    • Part B
    • Part D / Prescription Drug Benefits
    • Medicare for People Under 65
    • Medicare “Reform”
    • All Other Topics
    • Resources
      • Infographics
  • Publications
    • CMA Alerts
    • Fact Sheets & Issue Briefs
    • Infographics
    • The Medicare Handbook
    • SNF Enforcement Newsletter
    • Elder Justice Newsletter
    • Medicare Facts & Fiction
    • Articles by Topic
  • Litigation
    • Litigation News
    • Cases
    • Litigation Archive
    • Amicus Curiae Activities
  • Newsroom
    • Press Releases
    • Editorials & Letters to the Editor
    • CMA Comments, Responses, and Letters
    • Medicare Facts & Fiction
    • CMA in the News
  • About Us
    • Mission Statement
    • CMA FAQs
    • Personnel & Boards
    • The Center for Medicare Advocacy Founder’s Circle
    • Connecticut Dually Eligible Appeals Project
    • Ossen Medicare Outreach, Education and Advocacy Project
    • National Medicare Advocates Alliance
    • National Voices of Medicare Summit
    • CMA Webinars
    • Products & Services
    • Testimonials
    • Career, Fellowship & Internship Opportunities
    • Contact Us
  • Support Our Work
    • Donate Now
    • Join the Center for Medicare Advocacy Founder’s Circle
    • Take Action
    • Share Your Health Care Story
    • Tell Congress to Protect Our Care
    • Listen to Medicare & Health Care Stories
    • Sign Up

Dual Eligibles and Access to Part D Drugs: Pretty Good News from the OIG

July 26, 2018

Print Friendly, PDF & Email

The Office of the Inspector General for the Department of Health and Human Services released a report recently regarding Part D coverage of prescription drugs used by people dually eligible for Medicare and Medicaid. The June report, Part D Plans Generally Include Drugs Commonly Used by Dual Eligibles: 2018, found that most Part D plan formularies include prescription medications commonly used by dual eligible beneficiaries. The report’s findings include:

  • On average, Part D plan formularies include 96 percent of the 197 commonly used drugs (the list of the 200 drugs most commonly used by dual eligible was developed using data from the 2013 Medicare Current Beneficiary Survey – the most recent data available at the time of the study. The drugs most commonly used by dual eligible MCBS survey participants in 2013 account for 88 percent of all prescriptions dispensed to the dual-eligible respondents in the 2013 MCBS).
  • The average rate of inclusion decreased slightly between 2017 and 2018, from 97 percent to 96 percent.
  • 68 percent of the commonly used drugs are included by all Part D plan formularies.
  • The percentage of drugs to which plan formularies applied utilization management tools increased slightly between 2017 and 2018. On average, formularies applied utilization management tools to 29 percent of the unique drugs reviewed in 2018, an increase of 1 percentage point from 2017.
  • There are 386 unique formularies used by Part D plans in 2018. 12 formularies include 100 percent of the commonly used drugs. Two formularies include 85 percent of the commonly used drugs.
  • Of the approximately 10.8 million dual eligibles enrolled in Part D plans nationwide, approximately 93 percent are enrolled in Part D plans with formularies that include at least 90 percent of the commonly used drugs.
  • Seven percent of dual eligibles are enrolled in Part D plans that use formularies that include less than 90 percent of the commonly used drugs.

Access to Medicare Part D prescription drugs for people who are eligible for both Medicare and Medicaid appears to be holding fairly stable.  However, the report cautions that variation in plan formularies, and their use of utilization management might still force beneficiaries to make additional efforts to access the drugs they need, which could result in administrative barriers to accessing certain prescription drugs.

July 26, 2018 – K. Kertesz

Filed Under: Article Tagged With: alert, Medicaid, Medicare Part D / Prescription Drugs, Weekly Alert

Primary Sidebar

Easy Access to Understanding Medicare

The Center for Medicare Advocacy produces a range of informative materials on Medicare-related topics. Check them out:

  • Medicare Basics
  • CMA Alerts
  • CMA Webinars
  • Connecticut Info & Projects
  • Health Care Stories
  • Se habla Español

Sign Up for CMA Alerts

Jimmo v. Sebelius

Medicare covers skilled care to maintain or slow decline as well as to improve.

Improvement Isn’t Required. It’s the law!

Read more.

Latest Tweets

  • RT @medicarerights: A new issue brief from @RRFAging focuses on #economicsecurity in later life—the challenges & the solutions. Access… https://t.co/S9B27WnJP3, 7 hours ago
@CMAorg

Footer

Stay Connected:

  • Contact Us
  • Sitemap
  • Products & Services
  • Copyright/Privacy

© 2021 · Center for Medicare Advocacy